Easi Breathe

Quick links

Choose a section

Quick links to important sections

Advertisements

Easi Breathe

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Easi Breathe

Property Description
Active Ingredients Camphor, Chlorothymol, Eucalyptus Oil, Menthol, Terpineol
Form Liquid Inhalant Solution (Vaporiser Liquid)
Pharmacological Class Inhalational Decongestant (Respiratory Agent)
Common Use Symptomatic relief of nasal congestion and stuffiness
Origin Multicomponent blend of essential oil derivatives

What Type of Medicine is Easi Breathe?

Easi Breathe is a proprietary multicomponent aromatic formulation classified as a non-systemic, Inhalational Decongestant within the broad pharmacological category of Respiratory Agents. It is defined as a combination product because it utilizes a precise, synergistic blend of five distinct active ingredients to produce its therapeutic effect, differentiating it from single-substance preparations. The Liquid Inhalant Solution dosage form is specifically engineered for delivery via the inhalation route, ensuring its action is targeted locally within the upper respiratory tract without inducing systemic effects. Camphor, one of the components, is recognized for its role as a topical counter-irritant, an action that alleviates discomfort by gently stimulating local sensory pathways.


Composition: Active Ingredients and Origin

The preparation's identity is rooted in its five active components: Camphor, Chlorothymol, Eucalyptus Oil, Menthol, and Terpineol. The formula is fundamentally composed of volatile organic compounds and derivatives of essential oils. The inclusion of Eucalyptus Oil alongside high-purity terpene compounds like Menthol is a key feature that targets maximum volatility for effective vaporization. Inhaled menthol is associated with improving the subjective perception of nasal airflow, suggesting the formula aids breathing by enhancing the user's perception of air movement. The combination is primarily positioned for use by individuals seeking non-prescription, symptomatic relief for the common respiratory discomforts, such as the nasal stuffiness that frequently accompanies colds.


General Purpose: Non-Systemic Symptomatic Relief

The general purpose of Easi Breathe is to afford symptomatic relief for the temporary discomforts associated with acute upper respiratory congestion. Upon administration, the volatile constituents, notably Menthol, engage transient receptor potential channels in the nasal mucosa, producing a characteristic cooling sensation. This reflex stimulation enhances the subjective perception of air flowing through the nasal passages, which directly helps to alleviate the feeling of a blocked nose and promotes easier breathing without relying on vascular constriction or other systemic pharmacological actions.

Regulatory References

  1. Camphor Topical Uses and Side Effects (DailyMed)
Advertisements

What side effects are possible with Easi Breathe?

Easi Breathe, containing salbutamol, is a short-acting bronchodilator. Its safety profile is based on the therapeutic effects of stimulating beta-2 adrenergic receptors, which can lead to adverse reactions primarily affecting the nervous and cardiovascular systems.

Adverse Reactions and Frequency

Classification Common (ge 1/100 to < 1/10) Uncommon (ge 1/1000 to < 1/100) Rare (ge 1/10,000 to < 1/1000) Very Rare (< 1/10,000)
Nervous/Systemic Tremor, Headache Palpitations Hypokalemia, Peripheral Vasodilation Hyperactivity, Hypersensitivity Reactions
Cardiac Tachycardia - Arrhythmias (e.g., Atrial Fibrillation) Myocardial Ischaemia (Frequency Not Known)
Musculoskeletal Muscle Cramps - - -

Serious Adverse Reactions

Immediate medical attention is required for paradoxical bronchospasm, which presents as an unexpected, immediate increase in wheezing and breathlessness after inhalation. The medication must be discontinued immediately if this occurs. Hypersensitivity reactions, which include angioedema, urticaria, hypotension, and collapse, are rare but serious events. High-dose or prolonged use is associated with a potentially serious decrease in serum potassium (hypokalemia).

Safety Considerations and Limitations

  • Cardiovascular Effects: Caution is advised for patients with pre-existing heart conditions, including coronary insufficiency, cardiac arrhythmias, and hypertension, as beta-agonists can produce clinically significant cardiovascular effects.
  • Metabolic Effects: Caution is necessary in patients with thyrotoxicosis or diabetes mellitus, due to the drug's potential to affect blood glucose and potassium levels.
  • Dose Restriction: Increasing the dose or frequency of use beyond the prescribed regimen indicates a worsening of asthma control and necessitates a medical reassessment of the patient's overall asthma management, not simply an increase in reliever use.
  • Contraindications: The medicine is formally contraindicated in patients with a known hypersensitivity to the active substance or excipients.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose risk for this multi-component inhalant solution is primarily associated with accidental oral ingestion. Regulatory documentation from government health authorities classifies this as a potentially severe and life-threatening scenario, particularly for children, who are identified as a highly susceptible population for serious toxicity, even from small oral doses.

Documented Overdose Manifestations

Overdose presentations involve two phases: initial central nervous system (CNS) excitation, which may include agitation, confusion, tremors, and twitching facial muscles. This is often followed by CNS depression, leading to drowsiness, stupor, or unconsciousness. Documented systemic signs include gastrointestinal distress, such as vomiting, nausea, abdominal pain, and a burning sensation in the mouth or throat. Severe manifestations explicitly listed include rapid-onset seizures (convulsions), respiratory depression, and adverse cardiovascular effects like arrhythmias and hypotension.

Mandated Emergency Action

Regulatory labeling is explicit: in all cases of suspected overdose or accidental ingestion, users must seek immediate medical attention. It is mandated that a Poison Control Center be contacted immediately. There is no specific antidote available; therefore, the required procedural treatment is restricted to advanced symptomatic and supportive treatment to manage the critical effects on the respiratory, cardiovascular, and central nervous systems.

Advertisements

Therapeutic Uses of Easi Breathe

Easi Breathe is commonly used in situations involving certain distressing symptoms of the upper respiratory tract. It is applied across therapeutic domains where additional symptomatic support is needed, primarily to ease the symptom burden in non-severe, episodic conditions. The product is considered relevant for managing conditions characterized by periods of heightened symptoms, such as the common cold and seasonal allergic rhinitis.

This inhalational agent is applied in addressing symptom clusters related to nasal obstruction and stuffiness, supports the subjective feeling of airflow, and may assist with easing sinus pressure discomfort. This provides supportive relief when symptoms interfere with routine activities.

“The formulation is used for managing the physical strain and temporary discomfort associated with upper respiratory irritation.”

The product contributes to improved comfort during periods of heightened symptoms and may assist patients in coping more steadily with symptom fluctuations, offering supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Nasal Congestion The primary therapeutic focus is on providing temporary, localized symptomatic assistance for the discomfort of a blocked nose and associated pressure.

Regulatory References

  1. NIH DailyMed overview for Vaporizing Chest Rub
Advertisements

Eligibility and Restrictions for Use

This section summarizes the official population eligibility and non-eligibility for Easi Breathe (salbutamol) as defined in regulatory documentation.

Eligibility Scope

Populations for whom use is allowed:

  • Adults, adolescents, and children aged 4 years and over. Safety and effectiveness are generally not established for those younger than 4 years of age.

Populations for whom use is contraindicated:

  • Patients with a known hypersensitivity or allergy to the active substance (salbutamol) or any of the excipients in the medicine.
  • It is contraindicated for use in patients being treated for threatened abortion or premature labour (non-intravenous formulations).

Eligibility-Related Restrictions

Use of Easi Breathe should be approached with caution and is restricted to when strictly indicated by a healthcare professional in patients with certain pre-existing conditions. These include:

  • Cardiovascular Conditions: Those with severe heart disease, including coronary insufficiency (coronary artery disease), certain cardiac arrhythmias, and hypertension (high blood pressure).
  • Endocrine Conditions: Individuals with hyperthyroidism (overactive thyroid) or diabetes mellitus.
  • Pregnancy and Lactation: Use during pregnancy should only be considered if the expected benefit to the mother outweighs any possible risk to the fetus. Use in nursing mothers is generally not recommended unless necessary, due to the probable secretion of the active substance in breast milk.
Advertisements

What should I know about interactions with other medicines?

Easi Breathe Inhalant Capsules, containing a combination of aromatic compounds such as camphor, menthol, and eucalyptus oil, are primarily used via inhalation for relief of respiratory congestion. Due to this route of administration and the nature of the ingredients, the risk of significant drug-drug, drug-food, or drug-disease interactions is generally considered low compared to orally or systemically absorbed medications.

However, it is crucial to consider the following potential interactions and precautions, particularly with similar products or if accidental ingestion occurs:

Category Potential Concern
Drug-Drug No known significant systemic drug-drug interactions when used as directed (inhalation).
Drug-Disease Use with caution in patients with a history of asthma or other severe respiratory disorders, as some components could potentially trigger bronchospasm or irritation in sensitive individuals.
Topical Use Do not apply to broken or injured skin, as this could increase systemic absorption of camphor, leading to potential toxicity.
Ingestion Risk Never take orally, as ingestion can lead to serious systemic side effects due to the concentration of active ingredients like camphor and essential oils.

Always inform your healthcare provider about all medicines, herbal products, and supplements you use before starting Easi Breathe.

Advertisements

Mechanism of Action

How Easi Breathe Works: Molecular and Physiological Action


Targeted beta2-Adrenergic Receptor Engagement

Easi Breathe acts within domains involving receptor-mediated signaling by functioning as a beta2-adrenergic receptor agonist. It specifically binds to beta2-adrenergic receptors located on the smooth muscle cells lining the airways, initiating a signaling cascade that modifies the activity state of bronchial smooth muscle cells.


Influence on Key Second Messenger Pathways

The engagement of the beta2-receptors activates the enzyme adenylate cyclase, which rapidly increases the intracellular concentration of the second messenger cyclic adenosine monophosphate (cAMP). This increase in cAMP initiates a signaling sequence that modifies early molecular steps within the muscle cell.


Effect on Bronchial Smooth Muscle Tone

The molecular cascade leads to the activation of Protein Kinase A (PKA), resulting in the inhibition of processes that cause muscle contraction. This modification influences processes within the targeted pathways, resulting in the relaxation of the bronchial smooth muscle cells. This action induces a physiological adjustment involving the increase of the airway lumen diameter.

Advertisements

Dosage and Administration Information

How to use Easi Breathe — Administration Guidelines

The Easi Breathe inhaler is a breath-actuated device, meaning the medicine is released automatically when you breathe in through the mouthpiece. It is for inhalation use only, delivered through the mouth into the lungs.

Dosing and Frequency

Administration Scope Dosing Rules (Example: Salbutamol 100mcg/puff)
Route of Administration Inhalation (mouth)
Relief of Acute Symptoms One or two inhalations (100–200 micrograms) as needed.
Prevention (Exercise/Allergen) Two inhalations (200 micrograms) taken 10–15 minutes before exposure.
Chronic/Regular Therapy Up to two inhalations (200 micrograms) up to four times daily.
Maximum Daily Dose Must not exceed eight inhalations in 24 hours for relief use.
Wait Time Between Doses Must wait at least four hours between doses for chronic or on-demand use.

Procedural Steps

  1. Priming: Before first use, or if unused for five days or more (or two weeks for some steroid brands), the device must be test-sprayed by firing two shots into the air after shaking.
  2. Positioning: Sit or stand upright and hold the inhaler vertically and shake it vigorously.
  3. Inhalation: Open the cap, breathe out gently away from the inhaler, and place the mouthpiece firmly between your lips.
  4. Dosing: Breathe in slowly and deeply through the mouthpiece. Continue inhaling even after the dose puffs into your mouth. Do not block the air holes with your hand.
  5. Breath Hold: Remove the inhaler from your mouth and hold your breath for 10 seconds or for as long as is comfortable.
  6. Second Dose: If prescribed a second puff, wait about one minute, shake the inhaler again, and repeat the procedure.
  7. Post-Use: If the inhaler contains a steroid (such as Beclometasone), rinse your mouth with water and spit it out immediately after use to reduce local side effects.
Advertisements

Recent Clinical Evidence

Easi Breathe: Recent Clinical Evidence

Clinical evidence for Easi Breathe, which may contain a short-acting beta-2 agonist (SABA) such as salbutamol or an inhaled corticosteroid (ICS) like beclomethasone dipropionate, is based on controlled studies evaluating its effects on respiratory function and symptom management in individuals with asthma and Chronic Obstructive Pulmonary Disease (COPD).


Findings on Respiratory Function

Studies involving the SABA formulation indicated that administration was associated with a rapid onset of bronchodilation, typically within five minutes, with the effect generally persisting for four to six hours. This observation suggests an effect on reversible airway obstruction. Trials evaluating the ICS formulation, often in comparison to placebo, focused on pulmonary function over a 12-week period. These studies consistently reported measured improvements in forced expiratory volume in one second (FEV1) from baseline in pediatric and adult populations with mild to moderate persistent asthma, which is a key measure of lung function.

Clinical and Safety Observations

The research evidence supports the use of the SABA formulation for the relief of acute bronchospasm. For the ICS formulation, clinical trials observed a reduction in the use of rescue medication over the 12-week study duration compared to placebo, suggesting a potential role in improving asthma control.

Observed side effects across both formulations may include common events such as tremor, headache, and palpitations (with the SABA) or localized effects like oral thrush or throat irritation (with the ICS), particularly if proper technique or post-use rinsing is not implemented. Rare, but serious, effects like paradoxical bronchospasm or cardiovascular events have also been noted in post-marketing data for the SABA component. The overall profile indicates a pattern of effects consistent with other inhaled medications of the same classes.

Key Studies & References

  1. Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Easi Breathe (FAQ)


Q: Is Easi Breathe the same type of medicine as an inhaler I used before?

Easi Breathe is a brand name that may contain different active ingredients, depending on the specific product prescribed. One type is a Short-Acting Beta-2 Agonist (SABA), which is a fast-acting reliever medicine. Other formulations may contain an Inhaled Corticosteroid (ICS) for chronic control, or a non-systemic decongestant blend of aromatic compounds for symptom relief. Official documents describe these as different classes of medicine used for different purposes.


Q: How quickly does Easi Breathe usually start to work?

According to official product information for the Short-Acting Beta-2 Agonist (SABA) version, the effect is associated with an onset of action typically observed within 5 minutes of use. The perceived onset of action may vary depending on the specific Easi Breathe formulation and the patient’s condition.


Q: What does Easi Breathe feel like when it is working?

The sensation experienced can vary by formulation. The product information describes the decongestant formulation as producing a cooling sensation due to ingredients like menthol. For the SABA formulation, side effects such as tremor (shaking) or palpitations (a rapid heartbeat) are commonly reported.


Q: Is it safe to drink coffee while using Easi Breathe?

Official drug labels list possible cardiovascular effects, such as a rapid heart rate, that can occur with this class of medicine. While no specific drug interaction with caffeine is listed, the regulatory information advises caution in patients sensitive to sympathomimetic drugs (stimulants), a category which includes caffeine. Patients are generally advised to consult with a healthcare provider regarding any concerns about consuming caffeine while using this medicine.


Q: How long does the effect of one use of Easi Breathe typically last?

Official product information for the Short-Acting Beta-2 Agonist (SABA) formulation states that the duration of action is typically four to six hours in most patients. Regulatory documents state that if the duration of action is consistently shorter than expected, this observation warrants a discussion with a healthcare provider.


Q: Are there different strengths or versions of Easi Breathe?

Yes, Easi Breathe is a brand name used for different products. These products can vary in their active ingredients, such as salbutamol, an inhaled corticosteroid, or an aromatic decongestant blend, as well as the administered strength per dose. This variety allows the medicine to be used for different approved therapeutic indications.


Q: Why is Easi Breathe sometimes prescribed instead of other medicines?

Official documents indicate that the choice of medicine is related to its approved therapeutic role. A SABA formulation is indicated for the treatment or prevention of bronchospasm and provides short-acting bronchodilation. An ICS formulation is used to help achieve and maintain asthma control. The specific role needed informs the selection.


Q: Can Easi Breathe cause trouble sleeping or insomnia?

Official drug labels for the SABA formulation list hyperactivity and nervousness under nervous system disorders. These effects are listed in official documentation. These events, typically rare or very rare, are based on clinical reports and post-marketing data.


Q: Is Easi Breathe appropriate for use by children?

According to regulatory documents, the SABA formulation is indicated for use in adult and pediatric patients aged 4 years and older for the treatment or prevention of bronchospasm. Regulatory documents state that safety and effectiveness have generally not been established for children under 4 years of age.


Q: Can I use Easi Breathe if I am also taking vitamins?

Regulatory product documentation for the inhaled product does not list any known significant systemic interactions with vitamins or supplements when used as approved. Product information generally recommends that patients provide their healthcare provider with a complete list of all products they use.


Q: What is the difference between Easi Breathe and a bronchodilator?

A bronchodilator is a classification of medicine that acts to relax the muscles in the airways. One formulation of Easi Breathe (containing salbutamol/albuterol) is specifically a short-acting bronchodilator. However, the Easi Breathe brand also includes other medicine classes, such as Inhaled Corticosteroids or decongestant products.


Q: What is the risk of dependence or addiction with Easi Breathe?

Regulatory documents do not classify this medicine as having a risk of addiction or physical dependence. However, regulatory warnings caution against increasing the dose or frequency of use beyond what has been approved. Such an increase is described as an indication of worsening disease control that requires professional review.


Q: Are there restrictions on driving or operating machinery while using Easi Breathe?

Official product information for certain salbutamol formulations states that no adverse effects on the ability to drive or use machinery are known. However, patients should be mindful of potential side effects such as tremor or headache, which have the potential to affect concentration or performance.


Q: Is Easi Breathe considered a maintenance therapy?

The SABA formulation of Easi Breathe is primarily indicated as a rescue medication for acute symptoms. However, it is also approved for a Chronic Therapy dosing regimen (e.g., up to four times daily), which is used as part of long-term disease management. Official documentation indicates that the use of a formulation as either a rescue medication or part of a chronic treatment regimen is determined by its therapeutic indication.


Q: What if I travel to a different climate while using Easi Breathe?

Official storage instructions state the inhaler must be protected from frost and temperatures above 50 C as the contents are under pressure. The device should also not be refrigerated or frozen, as extreme cold temperatures may reduce its effectiveness. Adhering to these storage guidelines for temperature and protection from frost is generally necessary when traveling to climates with extreme conditions.


Q: Is it possible to be allergic to the inactive ingredients in Easi Breathe?

Yes, it is possible. Official documentation lists known hypersensitivity or allergy to the active substance or any of the excipients (inactive ingredients) in the medicine as a formal contraindication for use. Hypersensitivity reactions are also listed as a rare, serious adverse event.


Q: Has Easi Breathe been studied in pregnant or breastfeeding individuals?

Official documentation states that use during pregnancy should only be considered if the expected benefit to the mother outweighs any possible risk to the fetus. The medicine is generally not recommended for use in nursing mothers unless deemed necessary, due to the expectation that the active substance may be secreted in breast milk.


Q: Can Easi Breathe cause changes in mood or behavior?

The list of adverse reactions for the SABA formulation includes hyperactivity and nervousness under nervous system disorders. Official drug documents focus on specific listed adverse reactions, such as hyperactivity and nervousness, but do not typically address broader mood or psychiatric changes.


Q: What are the typical results seen in clinical trials of Easi Breathe?

For the SABA formulation, trials consistently show a rapid onset of bronchodilation and effects persisting for several hours. For the ICS formulation, typical results include measured improvements in Forced Expiratory Volume in one second ( FEV1) and a reduction in the use of rescue medication over time compared to placebo, indicating improved control.

Advertisements

How should Easi Breathe be stored and disposed of?

Storage and Disposal of Easi Breathe Inhalers

Easi Breathe inhalers must be stored under specific conditions to maintain efficacy and safety. The device must not be stored above 25 C and must be protected from frost and direct sunlight. Exposing the container to temperatures over 50 C is strictly prohibited as the contents are under pressure. The inhaler should not be refrigerated or frozen, as cold temperatures may reduce its effectiveness. The canister must also not be punctured, broken, or burned, even when empty.

For child safety, the inhaler should be kept out of the reach of children.

Any unused medicine or the empty canister must be disposed of in accordance with local regulatory requirements. Due to the pressurized nature of the container, it is typically required to return it to a local pharmacy for appropriate pharmaceutical waste handling, rather than disposing of it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Easi Breathe found in:

A-Z Index: